Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases.

Vaccine - 31 May 2018

Zhang Naru, Nandakumar Kutty Selva

Abstract excerpt

Chronic inflammatory autoimmune diseases leading to target tissue destruction and disability are not only causing increase in patients' suffering but also contribute to huge economic burden for the society. General increase in life expectancy and high prevalence of these diseases both in elderly and younger population emphasize the importance of developing safe and effective vaccines. In this review, at first the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Autoimmune Diseases
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitopes

Share to Lupus Erythematosus, Systemic

Share to Multiple Sclerosis

Share to Vaccines

Share to Vaccines, DNA

Source

Identifiers

PMID: 29706295
DOI: 10.1016/j.vaccine.2018.04.062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases.PMID 29706295Read ↗

Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccinationSemantic proximity Read ↗

COVID-19 vaccines and autoimmune disorders: A scoping review protocolSemantic proximity Read ↗

Vaccine against autoimmune disease: antigen-specific immunotherapySemantic proximity Read ↗

Novel<i>in silico</i>tools for designing peptide-based subunit vaccines and immunotherapeuticsSemantic proximity Read ↗

Infection and autoimmune disease.Semantic proximity Read ↗

Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid deliverySemantic proximity Read ↗

The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseasesSemantic proximity Read ↗

Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvantsSemantic proximity Read ↗

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious DiseasesSemantic proximity Read ↗

Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomesSemantic proximity Read ↗

Can Understanding the Pathogenesis of Autoimmune Hepatitis Lead to Rational Therapy?Semantic proximity Read ↗

A long and winding road to understand latent autoimmune diabetes in adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.